Add to ORKGhe invention relates to novel boronic acid compounds, a method for the preparation of such compounds, intermediate compounds for the preparation of such compounds, intermediate compounds for the use in a method for preparation of such compounds, a pharmaceutical composition, the use of one or more compounds discussed above or of a pharmaceutical composition in the manufacture of a medicament for the treatment of a bacterial infection, and a screening method
Recent decades have witnessed a dramatic increase of multidrug resistant (MDR) bacteria, compromisin...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
A small set of boronic acids acting as low nanomolar inhibitors of AmpC beta-lactamase were designed...
he invention relates to novel boronic acid compounds, a method for the preparation of such compounds...
The invention provides novel non-/9-lactam inhibitors of ^-lactamases. In particular, the invention ...
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
Disclosed herein inter alia are Boron containing compounds and methods for treating infections relat...
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
In response to the widespread use of beta-lactam antibiotics bacteria have evolved drug resistance m...
β-Lactamases (BLs) are among the main responsible of the threatening spread of Gram- negative pathog...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
With the aim of improving the ability of non-p-lactam inhibitors to inhibit AmpC-beta-tactamase, a s...
The widespread use of beta-lactam antibiotics has lead to the worldwide appearance of drug-resistant...
Provided herein are heterocyclic compounds and pharmaceutical formulations that can be used to treat...
Recent decades have witnessed a dramatic increase of multidrug resistant (MDR) bacteria, compromisin...
Recent decades have witnessed a dramatic increase of multidrug resistant (MDR) bacteria, compromisin...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
A small set of boronic acids acting as low nanomolar inhibitors of AmpC beta-lactamase were designed...
he invention relates to novel boronic acid compounds, a method for the preparation of such compounds...
The invention provides novel non-/9-lactam inhibitors of ^-lactamases. In particular, the invention ...
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
Disclosed herein inter alia are Boron containing compounds and methods for treating infections relat...
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
In response to the widespread use of beta-lactam antibiotics bacteria have evolved drug resistance m...
β-Lactamases (BLs) are among the main responsible of the threatening spread of Gram- negative pathog...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
With the aim of improving the ability of non-p-lactam inhibitors to inhibit AmpC-beta-tactamase, a s...
The widespread use of beta-lactam antibiotics has lead to the worldwide appearance of drug-resistant...
Provided herein are heterocyclic compounds and pharmaceutical formulations that can be used to treat...
Recent decades have witnessed a dramatic increase of multidrug resistant (MDR) bacteria, compromisin...
Recent decades have witnessed a dramatic increase of multidrug resistant (MDR) bacteria, compromisin...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
A small set of boronic acids acting as low nanomolar inhibitors of AmpC beta-lactamase were designed...